Lyell Immunopharma, Inc. - Common Stock — Cash Flow (NASDAQ:LYEL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -126.25 M-169.56 M-163.69 M-162.39 M-150.02 M -133.26 M Cash from investing activities -121.57 M-11.54 M184.05 M122.42 M54.1 M 4.98 M Cash from financing activities 401.24 M10.63 M1.74 M1.33 M50.41 M 102.47 M Free cash flow -126.25 M-169.56 M-163.69 M-162.39 M-150.8 M -133.97 M

News

Wall Street Analysts Think Lyell Immunopharma (LYEL) Could Surge 176.02%: Read This Before Placing a Bet

Lyell Immunopharma: Undervalued Ahead Of A Major CAR-T Inflection (NASDAQ:LYEL)

Lyell Immunopharma (LYEL) Loses 39.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript

Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Lyell Immunopharma (LYEL)

Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

A First Look At Lyell Immunopharma (NASDAQ:LYEL)

Lyell Immunopharma Stock (LYEL) Slides Despite Praise from a Top Wall Street Analyst - TipRanks.com

Morning News Wrap-Up 4/10/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet (NASDAQ:LYEL)

Citizens reiterates Lyell Immunopharma stock rating on trial progress

Avago, Lumentum among market cap stock movers on Monday